Form 4 for BHC Bausch Health Companies Inc.
Accepted 2022-04-04 00:00:00 ET · period of report 2022-03-31 · accession 0001127602-22-011296 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-04 | 2022-03-31 | BHC | Miller Steven D | Dir | A - Grant | $22.85 | +1,340 | 63.2K | +2% | +$30.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares, No Par Value | 2022-03-31 | A | A | 1,340 | $22.85 | 63,229 | D | — | — | (F1) Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. |